Estrogen-related receptors and the control of bone cell fate

Bone loss is naturally occurring in aging males and females and exacerbated in the latter after menopause, altogether leading to cumulative skeleton fragility and increased fracture risk. Two types of therapeutic strategies can be envisioned to counteract age- or menopause-associated bone loss, aimi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Carnesecchi, Julie (VerfasserIn) , Vanacker, Jean-Marc (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2016
In: Molecular and cellular endocrinology
Year: 2015, Jahrgang: 432, Pages: 37-43
ISSN:1872-8057
DOI:10.1016/j.mce.2015.07.019
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.mce.2015.07.019
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0303720715300265
Volltext
Verfasserangaben:Julie Carnesecchi, Jean-Marc Vanacker
Beschreibung
Zusammenfassung:Bone loss is naturally occurring in aging males and females and exacerbated in the latter after menopause, altogether leading to cumulative skeleton fragility and increased fracture risk. Two types of therapeutic strategies can be envisioned to counteract age- or menopause-associated bone loss, aiming at either reducing bone resorption exerted by osteoclasts or, alternatively, promoting bone formation by osteoblasts. We here summarize data suggesting that inhibition of the Estrogen-Related Receptors α and/or γ could promote bone formation and compensate for bone loss induced by ageing or estrogen-deficiency.
Beschreibung:Available online 20 July 2015
Gesehen am 29.04.2020
Beschreibung:Online Resource
ISSN:1872-8057
DOI:10.1016/j.mce.2015.07.019